The purpose of this study is to evaluate the efficacy of sodium thiosulfate (STS) infusion administered during cisplatin-containing chemotherapy cycles in reducing hearing loss in children with newly-diagnosed average-risk medulloblastoma.
Thank you for your interest, but this study is recruiting by invitation only.
United States (Nationwide)
David Kram
Pediatrics - Hematology/Oncology
Clinical or Medical
Interventional
Brain, Head, Nervous System
Cancer (Brain and Other Nervous System, Pediatric Cancers)
Child and Teen Health
Ear, Nose, and Throat
23-0210
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
